Primary Health Net
Visit our Public Information Site
Go to my LOC site
charity clinical briefing Mainline Con

Opchat Magazine Industry NewsIndustry News, April to June 2021

UKCA markings could leave sellers with a mountain of CE marked stock?
OSA hosts "Two key events for OSA members" in June 2021
Rayner Receives FDA Approval for RayOne Spheric Monofocal IOL
MIRAGE Green Challenge:The commitment of the Italian eyewear manufacturer for a sustainable world
British label EYE RESPECT, part of The GLBL Eyewear Group, expands distribution into Europe
Made for each other….Laboratoires Théa acquire The EyeBag® Brand
CooperVision announced its acquisition of No7 Contact Lenses.
Essilor Group to complete acquisition of Lenstec
New milestone for the Eye Doctor
AAO Urges Ophthalmic Equipment Manufacturers to Standardize Digital Imaging
Innovations, Ocuco's Lab Management Software, is awarded Best Optical Lab Software Vertical for 2021
DANSHARI inaugurates the new Logistics Centre in Montebelluna
OSA and ABDO to share benefits
Okia strengthens its commitment to green
Read the archived Industry News from January to March 2021

UKCA markings could leave sellers with a mountain of CE marked stock?

June 2021

OSA The Optical Suppliers Association held a very useful and informative webinar recently on the forthcoming law changes on Medical Device Agency regulations for spectacle frames, spectacle lenses, contact lenses and their supply.
Ann Blackmore led a discussion with a large number of OSA members who import and export both to the EU and Northern Ireland as well as providing home sales to UK optical providers.

Ann has been involved at almost all levels of European Laws effecting the Optical Confederation and is an independent adviser on such complicated matters and has been in past times advising FODO and continues to attend and sit on many of the key committees negotiating MDA adherence whilst trying like the profession did back in 2002 and before to ensure a light touch approach especially to the provision of spectacles either whole or as lens and frame parts.

Brexit has created an unusual divide not least between the UK and its Northern Ireland neighbours and of course the EU. One would have thought that the rules of engagement for safety and quality reasons would have allowed parity. Oh no, that's far too simple.

What we have now is a set of rules both from the EU and the UK MDA which create the goal posts positioning and the dates to work to but a lack of clear dimensions of said goals. In other words, the devil will be in the detail but from the UK perspective there is a lack of detail as yet.

In short, the CE mark that we all are very aware of on our frames we dispense and on the lens packets we receive will no longer be eligible past a grandfathering date to sell in the UK.

That date is 30th June 2023.

After that date companies cannot sell to UK opticians products with CE sole markings and opticians cannot ask glazers to glaze CE marked frames as they will not be deemed as a correctly adapted product for sale by glazing with UKCA marked lenses.

That is because from next year January 2022 the conforming frames and lenses will need be marked with the term UKCA (UK Conformity Accessed). Precise details (or the devilish small print) are yet to be formulated.

However those importers, manufacturers and wholesalers with conformity processes in place under the CE rules can also use them to apply for UKCA markings but will not need or be able to make a formal application for UKCA certification for at least 2 years. As eyewear is way down the list of importance. They will however be expected to have all their products UKCA marked post Jan 2022.

This gives everyone with CE marked frames and sunglasses, a mountain of products no doubt, 2 years to sell off the stock.

Sunglass and spectacle frame B2C traders as with businesses could always sell off your CE stock to opticians in the EU but you would need to provide a representative to hold your records of conformity and identity based in an EU country.

If you thought that was complicated, consider the companies selling to N Ireland. Their stock must be marked both with the CE and UKCA markings to comply!

One hopes that common-sense will prevail allowing, just as for reglazes, a glazer to verify the competency of a new CE only marked frame and judge it safe to glaze creating a perfectly adapted device.

Or is that wishful thinking!

Congrats to the OSA in attempting to bring its members up to date on what is a complicated issue.

OSA hosts "Two key events for OSA members" in June 2021

May 2021

Following a busy start to 2021, with the completion of the sale of the London headquarters, reduced subscription fees for members and a huge swathe of new member benefits thanks to a collaboration with ABDO, the OSA now has two important dates coming up in June.

Learn about Post-Brexit MDR Regs

On Thursday 3 June there will be a special meeting taking place for membership to discuss concerns about post-Brexit MDR regulation.

This is a thorny subject with potentially huge implications for OSA members. Following members’ feedback, the OSA called this meeting so that concerns, comments and questions on this issue can be gathered and put to the MHRA requesting the clearest possible guidance.

Anne Blackmore Optical Political Consultant

Ann Blackmore,
OSA Consultant, is chairing this meeting: ‘post-Brexit was always going to be a difficult time as manufacturers, importers and exporters got used to new rules and regulations. But it is doubly difficult for medical device manufacturers because the change has coincided with the introduction of new and different rules in the EU. That is why it is so important that the MHRA provides strong support and clear guidance.’ states Ann.

OSA Vice Chair Andy Hepworth adds ‘To call this a thorny subject probably understates the complexity of this area. The great news is that the OSA have again captured the thinking of Ann Blackmore to support our membership’. Members may also be interested to know that a ‘UK Regulations’ page has been added to the OSA website to help suppliers with regards to MDR and the future regulatory framework – please go to for more information.

Summer Members Event

Impending Brexit regulations and, of course, the Covid-19 pandemic hit everyone hard in 2020 and the annual December luncheon was postponed. Consequently, the OSA is holding a Summer Members’ Event to celebrate membership and the easing of lockdown measures.

Wednesday 23 June will see an unforgettable occasion for members at ‘The Oxfordshire’ hotel in Thame, Oxfordshire.

Members can network and meet up to relax with golf on a championship golf course, spa treatments, a meal and drinks as well as lavish overnight accommodation.

This will be at minimal cost to members to help celebrate a return to pre-lockdown life. A brief meeting will be held the next day to discuss any vital OSA business.

Stuart Burn OSA Chairman says: ‘I am delighted we are holding our first physical event in well over a year and look forward to seeing as many members as possible. We all have stories to share and this event should give us a fantastic chance to reflect on our experiences and look forward to the future, in very conducive surroundings’.

Rayner Receives FDA Approval for RayOne Spheric Monofocal IOL

May 2021

Rayner has received FDA approval for the RayOne Spheric fully-preloaded monofocal IOL. The approval marks Rayner’s third FDA approval in under 3 years within its RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA approval on March 26, 2021.

RayOne Spheric is positioned as a cost-effective monofocal IOL solution and benefits from the same fully preloaded injector as its siblings, according to a company news release. The RayOne injector requires only two steps to prepare (load OVD and close the wings) and is compatible with sub 2.2 mm incisions.

All three FDA-approved RayOne IOLs are based upon the same hydrophilic acrylic platform, which offers superb stability (0.08 mm mean decentration at 3-6 months1), low PCO (1.7% at 24 months2), and high-quality vision with a high Abbe value (563) and low refractive index (1.463), according to Rayner.

RayOne Spheric expands the RayOne portfolio in the United States as an economical option relative to RayOne Aspheric and RayOne EMV, and is a cost-effective solution for patients who want a modern, high-quality monofocal IOL.

“Rayner strives to offer superior patient outcomes for all patients, and as a cost-effective solution, RayOne Spheric ensures that all US surgeons and patients can access the highest quality IOLs,” Tim Clover, Rayner CEO, said in a company news release. “This third FDA approval in less than 3 years supports our continued efforts to grow our available portfolio in the United States, which is a key strategic focus for Rayner.”

Patient outcomes for all RayOne IOLs can be tracked using RayPRO, a free contactless telehealth solution that collects three years’ worth of patient reported outcomes after cataract or refractive surgery.

MIRAGE Green Challenge: The commitment of the Italian eyewear manufacturer for a sustainable world

May 2021

In progress the procedure for the UNI EN ISO 14001:15 certification for attesting the requirements of the environmental management system.

Mirage Green Challenge
Investments in advanced equipment and in energy efficient processes that contribute to a more sustainable use of resources and with a reduced impact on the environment; continuous research and development of new raw materials to produce sustainable, recycled and recyclable sunglasses; training of the personnel for a more ethical behavior at work: Mirage Occhiali has been designing and producing premium injected sunglasses for over 40 years and has been, for some time, an enterprise culture that promotes and supports sustainability.

A behaviour that anticipated the time, when 7 years ago the company chose to invest in the first totally electric machinery, reducing the consumption of polluting factors such as oil preferring renewable sources like electricity.

Today, 33% of the injection machines are in fact completely electric, with a 98.7% of saving in crude oils compared to the traditional manufacturing equipment.

The molds themselves are cooled with a free cooling system or with chillers that use air to cool down the temperature in place of traditional refrigerators. Moreover, a solar panel system allows Mirage to produce the 50% of the energy needs, while the rest of the energy comes from 100% renewable sources.

“We have been adopting a green behavior for a while because being sensitive to ethical and environmental themes is innate for us” – Cristiano Milone, Mirage CEO, declares – “One year ago we decided to start the procedure for the UNI EN ISO 14001:15 while recently we activated a project for verifying the carbon footprint of the whole manufacturing cycle; the results of this research will be available at the end of the year. At the same time, we select the business partners we choose to work with, preferring the ones that share our same values”.

Among the various steps that Mirage is taking for a greener business management, there are fully electric internal means of transportation, 100% LED lights, metal water bottles supply to all employees and electric cooling and heating system.

Born in the ‘60s as an assembling workshop, after a decade Mirage started producing injected frames purchasing the first machinery. Since then, they have been growing the expertise and know-how that is leading the company to introduce itself today as one of the most advanced organizations in the injection molding frames manufacturing.

British label EYE RESPECT, part of The GLBL Eyewear Group, expands distribution into Europe

May 2021

Eye Respect The British heritage-style independent label EYE RESPECT, created by Jonathan van Blerk in 2010 is expanding distribution of its ophthalmic and sunglasses collection to opticians across Europe. Until now, the label has focused mainly on the UK market and its vast celebrity clientele.

The brand’s new focus is on the European territories – and particularly Scandinavia, France, Italy and Spain – is part of a new re-structuring of its sales force at the company since it joined The GLBL Eyewear Group in 2020. The brand is also proud to have established a new HQ in Monaco, on the French Riviera, giving instant access to mainland Europe.

The EYE RESPECT collection continues to do well in the UK. We have a good number of strong accounts across the country, who have been fans from day 1,” says Jonathan Van Blerk, Founder of EYE RESPECT and The GLBL Eyewear Group. “It’s only natural that we should therefore extend the availability of this line to eyecare practitioners across Europe. The quality to price ratio has always been a huge factor for the success of this easy-to-wear and timeless range and we believe that the combination of honest and affordable pricing and attention to quality in each product will ensure that we can drive sales and leverage new opportunities going forward.”

EYE RESPECT: SS21 collection

Laboratoire Thea buys The Eye Bag Designed in Monaco and made in Italy, EYE RESPECT’s SS21 collection is defined by classic heritage shapes with universal appeal. The collection offers 5 timeless acetate models, each available in 5 colorways.

The colour palette is desirable and refined and includes trendy Crystal, Black Gloss, ever-popular Havana, classic Tortoiseshell as well as bright tones of Ink Blue. All the frames have been designed for optical or sun lenses.

Made for each other….Laboratoires Théa acquire The EyeBag® Brand

May 2021

Laboratoires Théa – a French family-owned pharmaceutical company, specialising in eye care around the world are delighted to announce that they have acquired The EyeBag® brand.

Laboratoire Thea buys The Eye Bag

The MGDRx EyeBag®, was launched 16 years ago by Prof. Teifi James, a consultant ophthalmologist, as a natural, effective treatment for dry eye, MGD, blepharitis and the symptoms associated with these conditions. It has been widely adopted by eye care professionals in the UK and fits perfectly into the range of products offered by Théa. “We are taking this new and exciting direction with Théa which will be good for our customers, our people, and the eye care sector,” commented Teifi James, MD, The EyeBag Co Ltd.

“This is an exciting addition to the Théa portfolio,” said Philip Lewis Williams, MD of Théa UK. “We have worked closely with Prof. James for a number of years, starting with the development of the Théa Dry Eye Project. The MGDRx EyeBag® is the missing piece in Théa’s Dry Eye and MGD portfolio. We are delighted that we can now offer a full range of products to patients and practitioners alike looking for a complete treatment of their Dry Eye. The products were simply made for each other.”

Laboratoires Théa’s research and development in the latest pharmacological treatments combined with its distribution network covering more than 70 countries, provides an ideal platform to introduce The EyeBag® to a global audience.

Whilst distribution transitions into the Théa network over the coming months, the product will continue to be available through your normal distributor or direct from the EyeBag sales team in Halifax.

Théa UK will inform all customers when the transition is complete and the MGDRx EyeBag® is available to be ordered through their own distribution channels.

CooperVision announced its acquisition of No7 Contact Lenses.

April 2021

The company will operate within the CooperVision Specialty EyeCare Group.

“No7 Contact Lenses has been our partner for several years in the UK while expanding its business,” said Juan Carlos Aragón, president of CooperVision Specialty EyeCare.

“The acquisition will enable us to directly offer more of our products through No7’s well-established channels, while expanding access to their designs. In tandem, the agreement should further accelerate the development of myopia management solutions in the UK.”

Ashley Pepper, managing director of No7 Contact Lenses, said: “We have great respect for CooperVision and have enjoyed a strong working relationship with its specialty eyecare team.

“Today’s news will help us have an even greater impact on the eyecare professionals who prescribe our contact lenses, and the adults and children whose vision and lives are made better because of them.”

No7 customers have been advised to continue to work with their current representatives and follow established ordering and support processes.

Essilor Group to complete acquisition of Lenstec

April 2021

The Essilor Group in the UK have announced their intention to complete the acquisition of the remainder of the Lenstec Optical Group shareholding from owners Nigel Castle and Gerard Donovan. The Essilor Group had acquired a minority shareholding through Shamir in 2016.

Olivier Chupin, Essilor’s VP North Europe commented, “We are pleased to reinforce our partnership with Lenstec which will allow us to improve access to the Essilor Group’s wide range of product offering to British consumers. The successful relationship that the Essilor Group enjoyed over the past years with the team at Lenstec has illustrated the relevancy of further combining Essilor’s technologies and know-how with the wealth of expertise and strong heritage of Lenstec. This addition presents us with a number of opportunities, across a broad range of market segments especially Key Accounts.”

Lenstec’s Managing Director, Nigel Castle, commented, “We are excited to continue our journey within the Group. The partnership with Essilor and Shamir allows us to both strengthen and extend our products and service offering to our valued customers, whilst retaining the same customer intimacy, service and solutions our customers have come to expect.”

Lenstec operates from three sites across the UK and enjoyed a turnover of £22m* in 2019.

The deal is expected to close during 2021 pending approval from the Competition and Markets Authority in the United Kingdom.

New milestone for the Eye Doctor

April 2021

The Eye Doctor receiving Queens Award
A patent has been granted for Sterileyes, an antibacterial shield on the Eye Doctor hot and cold compresses used to treat dry eye, Meibomian gland dysfunction (MGD) and blepharitis.

The Sterileyes solution is clinically proven to reduce bacteria by 99.9% and is bound to the fibres of the fabrics in the compress. Sterileyes also provides stain protection and eliminates the germs which create odour.

The granting of the patent is a major milestone for The Body Doctor, the family-run business behind the Eye Doctor range and comes after the company won the Queen’s Award for Innovation in 2016. The patent follows years of research and development with three independent laboratories.

“We have been pursuing the patent for five years for the UK and around the world as there are many false claims surrounding bacteria on compresses,” explained Managing Director of The Body Doctor, Sue Grant.

“We are led to believe that heating a compress in accordance with the manufacturer’s instructions will eliminate all bacteria, but this is false. It is also believed that if the compress filling has antibacterial properties, bacteria will not survive on the cover applied to the eyes which is also wrong. In addition, most compresses now offer hot and cold usage and, of course, no bacteria at all are killed when used cold.

The Eye Doctor Optical Barnding “After a long, arduous expensive journey through trials and testing, we feel our concerns for patients that are recommended a compress laden with bacteria have been borne out, particularly in this new world where people are more aware than ever of the risks of transference of bacteria and viruses.

“Several years ago, at great expense, we undertook the challenge of providing the safest, cleanest, and most cost-effective treatment available for patients suffering with MGD, blepharitis and dry eye disease. We are delighted that this journey has concluded with the grant of our patent to do just that.”

Contrary to popular belief not all bacteria on masks are killed in the microwave and millions more bacteria can be transferred from the eyes and face onto the eye compress during treatment. Increasing levels of bacteria on the compress may create the opportunity for cross-infection.

Ophthalmologist Dr Colin Parsloe explained: “Biofilm is a sticky protective substance that bacteria use to protect themselves from natural defence mechanisms and antibiotics. This protective biofilm can be found along the skin and base of the eyelashes of patients with anterior blepharitis and dry eye disease. These bacteria become more virulent and produce exotoxins including lipase which aggravates dry eye disease.

“I do have grave concerns about patients continuing to use contaminated hot compresses. Sterileyes is a breakthrough product and introduces a new paradigm shift we all must make in managing our dry eye patients.”

The Eye Doctor range is branded differently for the optical sector and the company offers practices the option to own brand at no additional cost. The company also provides the opportunity for a more favourable recommended retail price to optical patients.

The Eye Doctor range is distributed to the optical profession by Positive Impact.

AAO Urges Ophthalmic Equipment Manufacturers to Standardize Digital Imaging

April 2021

The American Academy of Ophthalmology, this week published a report urging ophthalmic imaging device manufacturers to standardize image formats to comply with the Digital Imaging and Communications in Medicine (DICOM) standard. DICOM is recognized in the United States and throughout the world as the medical imaging standard.

Widespread adoption of a uniform standard can revolutionize ophthalmology practices by promoting more efficient patient care, enabling the creation of comprehensive datasets for research and big data analyses, and developing algorithms for machine learning and artificial intelligence, according to an AAO news release.

This recommendation has already been endorsed by the American Society of Retina Specialists, the Asia-Pacific Academy of Ophthalmology, the Royal College of Ophthalmologists, and the Royal Australian and New Zealand College of Ophthalmologists

Lead author, Aaron Y. Lee, MD, MSCI, makes clear that the current lack of standardization in ophthalmology is holding back progress in the profession.

“One of the most important issues limiting clinical and research progress in the field of ophthalmology is the lack of standards for imaging and functional testing,” Dr. Lee said. “The new horizon of tools for digital healthcare rely on being able to interact algorithmically and extract data at scale. Right now, there has been great progress with electronic health record data becoming standardized and available directly to patients, but the same has not yet happened for imaging and functional testing data that we routinely collect in our clinics.”

Dr. Lee stressed that the benefit to patients would be significant. As physicians gain better access to images and reports, they can provide faster and more coordinated care, he said.

The Academy has long championed the DICOM standard, which includes a system of globally agreed-upon ophthalmological definitions. It promotes the seamless sharing of medical images by detailing how to format and exchange images and the information with which it is associated, such as the text describing the image and patient demographic information. DICOM compliance is low for ophthalmic imaging technologies. Even so-called “DICOM compliant” devices fail to fully meet DICOM standards. Currently, there is no easy way to exchange digital imaging data from one manufacturer’s equipment to another’s without creating a custom interface.

The report cites two specific examples of how ophthalmologists would benefit:

Provide machine-readable, discrete data for user selected reports of ophthalmic imaging or functional testing. Currently, when a patient’s OCT image or visual field test is stored, an ophthalmologist must retrieve and view that information separately, and then access the patient’s electronic medical record to obtain additional information about visual acuity and treatment history, etc.

There is no way to bring all the data in one place to inform clinical decision making.

Use of lossless compression for pixel or voxel data to encode the same raw data as used by manufacturers. When an imaging device or functional testing device captures data, it is often compressed to make the files smaller, which can degrade image quality. It is important for this data to be available from the manufacturers so ophthalmologists can provide the best quality care for our patients. Poor image quality can also lead to problems when AI models are being developed or new digital health tools are deployed.

“Other fields of medicine like Radiology have blazed ahead of our field by utilizing these standards to their fullest extent,” Dr. Lee said. “In some ways, it is much harder in our field because we have such a diverse variety of imaging devices and testing modalities. This variety is what makes ophthalmology so rich with information but also makes it difficult for standards to keep up with the constant innovation. My hope is that not only would vendors be willing to adopt and conform to standards but also be willing to define them for new modalities where the DICOM standard does not currently exist. The recommendations in this statement are just the first step in the direction that we need to go.”

“For most of the commonest causes of sight-loss in the UK, we are highly dependent on the remarkable imaging systems we use,” said Alastair Denniston, Consultant Ophthalmologist & Hon Professor, RCOphth Audit & Informatics Subcommittee. “But that can be severely limited if systems ‘won’t talk to each other’. The Royal College of Ophthalmologists is supporting this important global initiative from the AAO, as it is a key step towards ensuring maximal interoperability for improving care and accelerating research into these sight-threatening conditions.”

Daniel Ting, MD, Chair of the Asia Pacific Academy of Ophthalmology’s AI & Digital Innovation Standing Committee, adds: “The Asia-Pacific region, consisting of both developed and developing countries, is the home to 60% of the world’s population, accounting for up to 4.3 billion. Given the ageing population made worse by COVID-19 pandemic crisis, there is a pressing need for digital transformation in healthcare. In ophthalmology, the standardization of ocular imaging can facilitate the push for artificial intelligence, deep learning and big data analytics to enhance patients’ care and experience for global eye health. Thus, the Asia Pacific Academy of Ophthalmology (APAO) will support and endorse the AAO recommendation for ocular image standardization.”

Innovations, Ocuco's Lab Management Software, is awarded Best Optical Lab Software Vertical for 2021

April 2021

Innovations, Ocuco's Lab Management Software (LMS), has been awarded Best Optical Lab Software Vertical for 2021 by HealthCare Insights Magazine, which annually recognizes leading companies in the healthcare sector.

Innovations is Ocuco's flagship optical lab management software. Ocuco officially entered the LMS segment in 2008 with the acquisition of Innovations. Ocuco's CEO and founder Leo Mac Canna explains that the Innovations' acquisition was part of a strategy to expand its footprint in the USA. "Innovations, however, turned out to be much more than a trojan horse: it is a fantastic piece of software. Additionally, the IP and the team behind Innovations have driven huge improvements in our retail offerings while becoming technology leaders in the lab business."

Created by leading lab professionals about 30 years ago, Innovations offers customization, enables productivity and delivers real-time data analysis for optical labs. Innovations integrates every aspect of lens production into a modular, flexible and comprehensive package to support, streamline and advance businesses. Currently, Innovations is the LMS chosen by 2,700 optical labs around the globe.

Innovations evolves continuously, and it adapts to any lab configuration. Consequently, it can be installed on one PC or multiple workstations. Another unique feature in the software is the Rules Engine, which enables labs to use data to influence any aspect of production. Additionally, Innovations integrates with all OMA (Optical Manufacturers Association) compatible equipment. Innovations is scalable with no upper limit on production capacity, perfect for any expanding optical lab.

Zenni Optical emphasizes that Ocuco delivers flawless software and impeccable service. "Ocuco is a trusted partner of Zenni Optical. Following a smooth implementation of the Innovations LMS in 2014, we have continued to receive excellent technical support from the Ocuco team. As a result, we are happy to recommend Ocuco and Innovations to industry peers," says Julia Zhen, Zenni's Optical Founder & CEO.

Looking to the future, Ocuco believes that cloud-based systems are here to stay. Thus, the company is focusing on leveraging this technology to enhance its products further. Delineating on the company's long-term goal, Leo adds, "Ocuco indeed will play a significant role in the eyecare industry as a pure technology company. Our long-term plans include consolidating Ocuco globally as a reference in software for the eyecare industry."

DANSHARI inaugurates the new Logistics Centre in Montebelluna

April 2021

The warehouse based in Italy will handle shipments to Europe, Middle East, Africa and Latin America

On February 15th Danshari inaugurated the new logistics center in Montebelluna, in the province of Treviso, with the aim of guaranteeing a more qualified and punctual service to its optical customers.

The warehouse is managed with the most modern picking softwares that guarantee operational efficiency, high productivity and reduced shipping times, allowing the company to coordinate in the best and quickest way all orders in order to process them in a maximum of two days to Europe, the Middle East, Africa, and Latin America.

The warehouse will be used as a hub for the collection and shipping of POP materials, samples and spare parts.

As stated by Giuseppe La Boria, CEO of Danshari, “One of the cornerstones of Danshari philosophy is customer service. An aspect that is expressed not only with offering very high quality products, but also with particular attention to pre and post-sales customer service”.

The warehouse in Montebelluna will handle shipments to Europe, Middle East, Africa and Latin America, while all shipments to Asia will continue to be handled by Hong Kong warehouse.

OSA and ABDO to share benefits

April 2021

Optical Suppliers Association OSA

The Optical Suppliers Association (OSA) joins forces with the Association of British Dispensing Opticians (ABDO) to increase the benefits for its members.

From now onwards all OSA members will be eligible to join the ABDO benefits programme.

In addition to the existing range of member benefits, this provides individuals with an enormous array of health and lifestyle benefits from discounts in high street stores such as M&S and Waitrose, concessions on Apple products, lower insurance rates, reduced gym memberships and much more.

Stuart Burn

OSA Chairman, Stuart Burn says " This is a very exciting step for the OSA...

There has never been a more important time to focus on wellbeing and by collaborating with ABDO we have delivered to our members and employees and exceptional array of benefits and discounts. This programme will allow members to enjoy exciting resources away from work and we are delighted to be able to facilitate that"

Sir Anthony Garrett

Sir Anthony Garrett
ABDO General Secretary commented, "I am delighted that OSA members can now access ABDO Lifestyle benefits. There has always been a close link between Dispensing Opticians in practice and our partners in industry who provide both equipment and product. I hope that this initiative will be the start of a new and even closer working relationship”

More about the Optical Suppliers Association

The OSA provides a platform for the optical industry to network, engage, influence regulation and spearhead developments in optics in the UK.

It provides a thriving network for companies involved in all aspects of manufacturing, distribution and supply to optical practices.

Optical Industry companies can get access to all these great benefits, by becoming an OSA member

Okia strengthens its commitment to green

April 2021

1 million bottles recycled into eyewear by 2021

Okia Reshape Campaign
One million of bottles to be recycled and turned into eyewear by 2021: this is the goal of OKIA, the Hong Kong-based eyewear company recognized worldwide for its patented HDA® Technology.

Thanks to the launch of the RESHAPETM project to produce eyewear entirely made of 100% recycled PET material from plastic bottles, the company never stops its commitment in promoting a green attitude, on the contrary it raises the bar to reach this ambitious target this year.

Each RESHAPETM model is made from 5 recycled water bottles and includes lenses which are biodegraded into water, carbon and biomass. According to the recent upgrade in the technology, with this material it is possible to produce eyewear even thinner and ultralight, very flexible and with a wider color range.

“According to recent trends, fashion brands aim to be 100% sustainable by 2025. I’m proud to say that we have been really pioneer in this subject when we launched the RESHAPETM material two years ago” says Jacky Lam, Managing Director at OKIA.

Moving into rPET will shift the industry forward, keeping plastic out of oceans and landfill, and reduce energy, CO2 and oil resources, recycling that will ultimately offer more potential for circularity in the future. Bottles are an abundant global waste stream and a relatively clean and low-chemical feedstock.



heidelberg side banner
Office Giant
Primary Health Net